Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

716 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The SIL index is a simple and objective prognostic indicator in diffuse large B-cell lymphoma.
Tomita N, Suzuki T, Miyashita K, Yamamoto W, Motohashi K, Tachibana T, Takasaki H, Kawasaki R, Hagihara M, Hashimoto C, Takemura S, Koharazawa H, Yamazaki E, Taguchi J, Fujimaki K, Fujita H, Sakai R, Fujisawa S, Motomura S, Kawamoto K, Sone H, Takizawa J. Tomita N, et al. Among authors: takemura s. Leuk Lymphoma. 2016 Dec;57(12):2763-2770. doi: 10.1080/10428194.2016.1195498. Epub 2016 Jun 20. Leuk Lymphoma. 2016. PMID: 27320054
Serum ferritin level is a prognostic marker in patients with peripheral T-cell lymphoma.
Koyama S, Fujisawa S, Watanabe R, Itabashi M, Ishibashi D, Ishii Y, Hattori Y, Nakajima Y, Motohashi K, Takasaki H, Kawasaki R, Hashimoto C, Yamazaki E, Koharazawa H, Takemura S, Tomita N, Sakai R, Motomura S, Nakajima H. Koyama S, et al. Among authors: takemura s. Int J Lab Hematol. 2017 Feb;39(1):112-117. doi: 10.1111/ijlh.12592. Epub 2016 Nov 24. Int J Lab Hematol. 2017. PMID: 27885817 Clinical Trial.
Long-term outcome of L86 and L97 protocols for adult acute lymphoblastic leukemia.
Koharazawa H, Kanamori H, Sakai R, Hashimoto C, Takemura S, Hattori M, Taguchi J, Fujimaki K, Tomita N, Fujita H, Fujisawa S, Harano H, Ogawa K, Motomura S, Maruta A, Ishigatsubo Y. Koharazawa H, et al. Among authors: takemura s. Leuk Lymphoma. 2008 Nov;49(11):2133-40. doi: 10.1080/10428190802464711. Leuk Lymphoma. 2008. PMID: 19021056 Clinical Trial.
[ABVD chemotherapy for Hodgkin lymphoma at a single institute].
Ohshima R, Motomura S, Hashimoto C, Miyazaki T, Ito S, Takasaki H, Hyo R, Koharazawa H, Takemura S, Yamazaki E, Fujimaki K, Tomita N, Fujita H, Fujisawa S, Harano H, Kanamori H, Ishigatsubo Y. Ohshima R, et al. Among authors: takemura s. Rinsho Ketsueki. 2010 Dec;51(12):1756-61. Rinsho Ketsueki. 2010. PMID: 21258185 Japanese.
Phase II study of CHOP-GR therapy in diffuse large B-cell lymphoma.
Takemura S, Tomita N, Koharazawa H, Fujimaki K, Harano H, Hyo R, Yamazaki E, Hashimoto C, Miyazaki T, Ishigatsubo Y. Takemura S, et al. Int J Hematol. 2012 Aug;96(2):241-6. doi: 10.1007/s12185-012-1119-5. Epub 2012 Jun 10. Int J Hematol. 2012. PMID: 22684897 Clinical Trial.
716 results